Chemotherapy reduces PARP1 in cancers of the ovary: implications for future clinical trials involving PARP inhibitors.
about
Profile of olaparib in the treatment of advanced ovarian cancerCTCF facilitates DNA double-strand break repair by enhancing homologous recombination repair.Hormone receptor expression profiles differ between primary and recurrent high-grade serous ovarian cancersNew perspective on maintenance therapies for platinum- sensitive recurrent ovarian cancer in women with germline and somatic mutations in BRCA1 and BRCA2 genesAssessment of PARP protein expression in epithelial ovarian cancer by ELISA pharmacodynamic assay and immunohistochemistry.Non-alcoholic fatty liver disease in mice with heterozygous mutation in TMED2.RBR-type E3 ubiquitin ligase RNF144A targets PARP1 for ubiquitin-dependent degradation and regulates PARP inhibitor sensitivity in breast cancer cells.
P2860
Q26749284-69BA2F2A-0A30-4FCF-9E6C-2FDDF3F07254Q33725333-9DA1B34B-C914-44F5-9303-4B3A0BEA7498Q33779282-E64C92C8-CDEE-4EF1-9CC9-01EF9D98655FQ37519943-82DD9D0F-6491-4FD3-BF1F-833811B261CEQ38377713-AC500D21-9099-4E03-92B7-2E7D5E2C274DQ38630243-8DA6EE15-3ABB-49BD-A5F2-4F3284E5609AQ47156447-8AB03BD9-0EFE-4349-B2E7-B0FB33658A78
P2860
Chemotherapy reduces PARP1 in cancers of the ovary: implications for future clinical trials involving PARP inhibitors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Chemotherapy reduces PARP1 in ...... als involving PARP inhibitors.
@ast
Chemotherapy reduces PARP1 in ...... als involving PARP inhibitors.
@en
type
label
Chemotherapy reduces PARP1 in ...... als involving PARP inhibitors.
@ast
Chemotherapy reduces PARP1 in ...... als involving PARP inhibitors.
@en
prefLabel
Chemotherapy reduces PARP1 in ...... als involving PARP inhibitors.
@ast
Chemotherapy reduces PARP1 in ...... als involving PARP inhibitors.
@en
P2093
P2860
P1433
P1476
Chemotherapy reduces PARP1 in ...... ials involving PARP inhibitors
@en
P2093
Diane Provencher
Hubert Fleury
Ido Laskov
Manuela Pelmus
Marie-Claude Beauchamp
Maud Marques
Michael Witcher
Walter H Gotlieb
P2860
P2888
P356
10.1186/S12916-015-0454-9
P407
P577
2015-09-09T00:00:00Z
P5875
P6179
1006952232